Literature DB >> 19233246

FMR1: a gene with three faces.

Ben A Oostra1, Rob Willemsen.   

Abstract

The FMR1 gene is involved in three different syndromes, the fragile X syndrome (FXS), premature ovarian insufficiency (POI) and the fragile X-associated tremor/ataxia syndrome (FXTAS) at older age. Fragile X syndrome is caused by an expansion of a CGG repeat above 200 units in the FMR1 gene resulting in the absence of the FMR1 mRNA and protein. The FMR1 protein is proposed to act as a regulator of mRNA transport and of translation of target mRNAs at the synapse. FXS is seen as a loss of function disorder. POI and FXTAS are found in individuals with an expanded repeat between 50 and 200 CGGs and are associated with increased FMR1 mRNA levels. The presence of elevated FMR1 mRNA in FXTAS suggests that FXTAS may represent a toxic RNA gain-of-function effect. The molecular basis of POI is yet unknown. The role of the FMR1 gene in these disorders is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233246      PMCID: PMC2692361          DOI: 10.1016/j.bbagen.2009.02.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  128 in total

1.  Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.

Authors:  David Hessl; Flora Tassone; Danuta Z Loesch; Elizabeth Berry-Kravis; Maureen A Leehey; Louise W Gane; Ingrid Barbato; Cathlin Rice; Emma Gould; Deborah A Hall; James Grigsby; Jacob A Wegelin; Susan Harris; Foster Lewin; Dahlia Weinberg; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

2.  Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons.

Authors:  L N Antar; J B Dictenberg; M Plociniak; R Afroz; G J Bassell
Journal:  Genes Brain Behav       Date:  2005-08       Impact factor: 3.449

3.  Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome.

Authors:  Roberto Galvez; William T Greenough
Journal:  Am J Med Genet A       Date:  2005-06-01       Impact factor: 2.802

4.  Stability of the human fragile X (CGG)(n) triplet repeat array in Saccharomyces cerevisiae deficient in aspects of DNA metabolism.

Authors:  P J White; R H Borts; M C Hirst
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

5.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

Authors:  Q J Yan; M Rammal; M Tranfaglia; R P Bauchwitz
Journal:  Neuropharmacology       Date:  2005-07-27       Impact factor: 5.250

6.  Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.

Authors:  S K E Koekkoek; K Yamaguchi; B A Milojkovic; B R Dortland; T J H Ruigrok; R Maex; W De Graaf; A E Smit; F VanderWerf; C E Bakker; R Willemsen; T Ikeda; S Kakizawa; K Onodera; D L Nelson; E Mientjes; M Joosten; E De Schutter; B A Oostra; M Ito; C I De Zeeuw
Journal:  Neuron       Date:  2005-08-04       Impact factor: 17.173

7.  Microtubule-dependent recruitment of Staufen-green fluorescent protein into large RNA-containing granules and subsequent dendritic transport in living hippocampal neurons.

Authors:  M Köhrmann; M Luo; C Kaether; L DesGroseillers; C G Dotti; M A Kiebler
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

8.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

9.  Cognitive decline, neuromotor and behavioural disturbances in a mouse model for fragile-X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Debby Van Dam; Vanessa Errijgers; R Frank Kooy; Rob Willemsen; Edwin Mientjes; Ben A Oostra; Peter Paul De Deyn
Journal:  Behav Brain Res       Date:  2005-07-30       Impact factor: 3.332

10.  Neurotrophin regulation of beta-actin mRNA and protein localization within growth cones.

Authors:  H L Zhang; R H Singer; G J Bassell
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

View more
  60 in total

Review 1.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

2.  Fragile X mental retardation protein levels are decreased in major psychiatric disorders.

Authors:  S Hossein Fatemi; Rachel E Kneeland; Stephanie B Liesch; Timothy D Folsom
Journal:  Schizophr Res       Date:  2010-08-19       Impact factor: 4.939

3.  Distance delivery of a spoken language intervention for school-aged and adolescent boys with fragile X syndrome.

Authors:  Andrea McDuffie; Amy Banasik; Lauren Bullard; Sarah Nelson; Robyn Tempero Feigles; Randi Hagerman; Leonard Abbeduto
Journal:  Dev Neurorehabil       Date:  2017-09-28       Impact factor: 2.308

4.  Screening for intermediate CGG alleles of FMR1 gene in male Iranian patients with Parkinsonism.

Authors:  Atefeh Entezari; Mahmoud Shekari Khaniani; Tayyeb Bahrami; Sima Mansoori Derakhshan; Hossein Darvish
Journal:  Neurol Sci       Date:  2016-10-01       Impact factor: 3.307

5.  Progressive spatial processing deficits in a mouse model of the fragile X premutation.

Authors:  Michael R Hunsaker; H Jürgen Wenzel; Rob Willemsen; Robert F Berman
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

6.  Ubiquitin-positive intranuclear inclusions in neuronal and glial cells in a mouse model of the fragile X premutation.

Authors:  H Jürgen Wenzel; Michael R Hunsaker; Claudia M Greco; Rob Willemsen; Robert F Berman
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

7.  Screening for the presence of FMR1 premutation alleles in a Spanish population with fibromyalgia.

Authors:  Loreto Martorell; Mireia Tondo; Ferrán Garcia-Fructuoso; Montserrat Naudo; Cayetano Alegre; Josep Gamez; Jordi Genovés; Pilar Poo
Journal:  Clin Rheumatol       Date:  2012-08-18       Impact factor: 2.980

8.  Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles.

Authors:  Jun Yi Wang; David Hessl; Christine Iwahashi; Katherine Cheung; Andrea Schneider; Randi J Hagerman; Paul J Hagerman; Susan M Rivera
Journal:  Neuroimage       Date:  2012-10-12       Impact factor: 6.556

9.  Aging in fragile X syndrome.

Authors:  Agustini Utari; Evan Adams; Elizabeth Berry-Kravis; Alyssa Chavez; Felicia Scaggs; Lily Ngotran; Antoniya Boyd; David Hessl; Louise W Gane; Flora Tassone; Nicole Tartaglia; Maureen A Leehey; Randi J Hagerman
Journal:  J Neurodev Disord       Date:  2010-05-12       Impact factor: 4.025

10.  Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10.

Authors:  Misti C White; Rui Gao; Weidong Xu; Santi M Mandal; Jung G Lim; Tapas K Hazra; Maki Wakamiya; Sharon F Edwards; Salmo Raskin; Hélio A G Teive; Huda Y Zoghbi; Partha S Sarkar; Tetsuo Ashizawa
Journal:  PLoS Genet       Date:  2010-06-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.